
Researchers find a hint at how to delay Alzheimer's symptoms. Now they have to prove it
If blocked funding stops Heinrichs' doses, 'how much time do we have?' asked his wife, Rachel Chavkin. 'This trial is life.'
Advertisement
Two drugs sold in the US can modestly slow worsening of early-stage Alzheimer's by clearing the brain of one of its hallmarks, a sticky gunk called amyloid. But until now, there haven't been hints that removing amyloid far earlier – many years before the first symptoms appear – just might postpone the disease.
Get Starting Point
A guide through the most important stories of the morning, delivered Monday through Friday.
Enter Email
Sign Up
The research led by Washington University in St. Louis involves families that pass down rare gene mutations almost guaranteeing they'll develop symptoms at the same age their affected relatives did – information that helps scientists tell if treatments are having any effect.
The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight years. Long-term amyloid removal cut in half their risk of symptom onset, researchers reported Wednesday in the journal Lancet Neurology.
Despite the study's small size, 'it's incredibly important,' said Northwestern University neuroscientist David Gate, who wasn't involved with the research.
Now participants have been switched from an earlier experimental drug to Leqembi, an IV treatment approved in the US, to try to answer the obvious next question.
'What we want to determine over the next five years is how strong is the protection,' said Washington University's Dr. Randall Bateman, who directs the Dominantly Inherited Alzheimer's Network of studies involving families with these rare genes. 'Will they ever get the symptoms of Alzheimer's disease if we keep treating them?'
Advertisement
Here's the worry: Bateman raised money to start that confirmatory study while seeking National Institutes of Health funding for the full project but his grant has been delayed as required reviews were canceled. It's one example of how millions of dollars in research have been stalled as NIH grapples with funding restrictions and mass firings.
At the same time researchers wonder if NIH will shift focus away from amyloid research after comments by Dr. Jay Bhattacharya, nominated as the agency's new director.
'One of the reasons I think that we have not made progress in Alzheimer's, as much as we ought to have, is because the NIH has not supported a sufficiently wide range of hypotheses,' Bhattacharya told senators, responding to one who brought up an example of earlier science misconduct unrelated to current research.
Scientists don't know exactly what causes Alzheimer's, a mind-destroying disease that affects nearly 7 million Americans, mostly late in life. What's clear is that silent changes occur in the brain at least two decades before the first symptoms -- and that sticky amyloid is a major contributor. At some point amyloid buildup appears to trigger a protein named tau to begin killing neurons, which drives cognitive decline.
Tau-fighting drugs now are being tested. Researchers also are studying other factors including inflammation, the brain's immune cells and certain viruses.
NIH's focus expanded as researchers found more potential culprits. In 2013, NIH's National Institute on Aging funded 14 trials of possible Alzheimer's drugs, over a third targeting amyloid. By last fall, there were 68 drug trials and about 18% targeted amyloid.
Northwestern's Gate counts himself among scientists who 'think amyloid isn't everything,' but said nothing has invalidated the amyloid hypothesis. He recently used brain tissue preserved from an old amyloid study to learn how immune cells called microglia can clear those plaques and then switch to helping the brain heal, possible clues for improving today's modest therapies.
Advertisement
For now, amyloid clearly is implicated somehow and families with Alzheimer's-causing genes are helping answer a critical question for anyone at risk: Can blocking amyloid buildup really stave off symptoms? Without NIH funding, Bateman said, that opportunity will be lost.
'It's absolutely insane,' said longtime study participant June Ward, who lives near Asheville, North Carolina, and plans to ask friends to complain to lawmakers.
Ward turns 64 in June and is healthy, two years older than when her mother's symptoms appeared. 'It is exciting to think about the possibility that Alzheimer's disease might not be what gets me,' she said.
In New York, Heinrichs said he has hope that his 3-year-old son won't 'experience the stress and sorrow that I lived through as a young man to watch my father fade away.'
'We need the NIH to be not politicized,' added Chavkin, his wife. 'It's just about keeping people alive or helping them live better. And in this case, it's helping my husband survive.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


UPI
6 minutes ago
- UPI
NIH study links cigarette cessation with drug, alcohol addiction recovery
On Wednesday, scientists at the National Institutes of Health in Bethesda, Md. (pictured in March), said fresh data in its nearly 15-year-old ongoing PATH study with the FDA is suggesting longer-term remission from drug or alcohol addiction is more likely if a person also quits cigarettes at the same time. File Photo by Annabelle Gordon/UPI | License Photo Aug. 13 (UPI) -- A new federal study is linking the ability to quit smoking with longer-term success from the grip of drug or alcohol addiction, as well. Scientists at the National Institutes of Health on Wednesday said that fresh data in its nearly 15-year-old ongoing PATH study with the U.S. Food and Drug Administration is suggesting that sustained remission from drug or alcohol addiction is more likely to be achieved if a person also quits cigarettes at the same time versus separately. The PATH study, or Population Assessment of Tobacco and Health Study, has been ongoing for more than a decade in an attempt to better understand the health effects of smoking. "It underscores the importance of addressing different addictions together, rather than in isolation," Dr. Nora Volkow director of NIH's National Institute on Drug Abuse, said in a statement. Health officials pointed out that people in addiction also have a higher likelihood of being addicted to nicotine. The longitudinal NIH analysis showed a 42% greater odd of going from a "current" to "former" smoker if a person is already working in a recovery stage from a non-tobacco vice. Volkow added that NIH national sampling is "strong evidence" that quitting cigarette smoking "predicts improved recovery from other substance use disorders." The federally funded PATH study analyzed more than 2,650 participants age 18 or older with a history of substance abuse but with a change in recovery over a four-year period. As part of the study, NIH researchers asked annual questions of participants concerning smoking habits and use of other items. "Although the health benefits of quitting smoking are well-known, smoking cessation has not been seen as a high priority in drug addiction treatment programs," stated Dr. Wilson Compton, deputy director of NIDA and the study's senior author. The study's authors highlighted it's uniqueness but noted it was only suggestive in nature, that prior studies had utilized addiction-specific data out of U.S. drug and alcohol treatment centers that "could not adequately test for an association" with cigarette smoking. Compton said the findings "bolster support for including smoking cessation as part of addiction treatment." Officials at NIH said its researchers have an "increasing confidence" in the belief the new finding are "generalizable to the millions of adults" in the throes of alcohol or drug addiction in the United States. However, they added that further research is needed to "definitively establish" a causal connection.


Newsweek
an hour ago
- Newsweek
Drinking Rate Plunges to Record Low in US, New Poll Shows
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Alcohol consumption among U.S. adults has fallen to its lowest recorded level in nearly 90 years, with 54 percent saying they drink, down from 58 percent a year ago, according to Gallup's latest annual survey. Why It Matters Gallup has tracked alcohol consumption among U.S. adults since 1939. The latest figure falls below the previous record low of 55 percent in 1958. The poll also found that a majority of Americans, 53 percent, believe that moderate drinking is bad for one's health. Alcohol can lead to many health problems, including liver diseases and increased risk of some cancers. Mixed drinks are displayed at a bar in Baltimore on February 8, 2023. Mixed drinks are displayed at a bar in Baltimore on February 8, 2023. AP Photo/Julio Cortez What To Know The latest Gallup survey, conducted July 7-21, found that a smaller share of Americans are drinking alcohol than at any point in the poll's history. In the mid-1970s, the share peaked at 71 percent for three consecutive years starting in 1976. Since then, drinking rates have generally trended downward, averaging about 60 percent, with periodic rises and dips. In 2022, 67 percent of adults said they drank alcohol, which Gallup noted as an outlier, followed by 62 percent in 2023, 58 percent in 2024 and 54 percent this year. The poll found that the decline in drinking is disproportionately among women, down 11 percentage points since 2023, to 51 percent, whereas men are down 5 points, at 57 percent. Along party lines, 61 percent of surveyed Democrats drink compared with 46 percent of Republicans. A record-low 54% of Americans say they consume alcohol. — Gallup (@Gallup) August 13, 2025 The survey also found that 53 percent of Americans say drinking in moderation, which is one to two drinks a day, is bad for one's health. Thirty-seven percent believe it does not make a difference. The results come as 45 percent of Americans believe moderate drinking is bad for health, according to a Gallup poll last year. That poll found drinking beliefs vary greatly among age groups, with 65 percent of young U.S. adults aged 18 to 34 believing that alcohol consumption negatively affects one's health, while 37 percent and 39 percent hold that view among those aged 35 to 54 and 55 and older, respectively. The view has shifted sharply in recent years. Between 2001 and 2011, about 25 percent of Americans said drinking was good for one's health. Women are more likely than men to view moderate drinking as unhealthy, 60 percent to 47 percent, respectively. The poll also found the lowest recorded figure of average number of drinks over the past week since 1996 at 2.8. What People Are Saying Lydia Saad, Gallup's director of social research, in the August 13 survey announcement: "The declines in alcohol consumption does not appear to be caused by people shifting to other mood-altering substances—in particular, recreational marijuana, which is now legal in about half of U.S. states." The Office of the Surgeon General, in a January 2025 announcement: "Alcohol consumption is the third-leading preventable cause of cancer in the United States, after tobacco and obesity." What Happens Next As Americans' drinking habits shift, the change is expected to affect the alcohol industry as well as the growing market for alternative beverages, driven in part by rising health concerns.


Axios
2 hours ago
- Axios
A record share of Americans are giving booze the boot
The percentage of U.S. adults consuming alcohol has hit a new low, according to Gallup data released Wednesday. The big picture: The share of Americans who say that drinking in moderation is detrimental to one's health hitting a historic high, a belief that's echoed by recent scientific research. Driving the news: In 2025, just over half (54%) of U.S. adults reported having alcoholic beverages on occasion. Between 1997 and 2023, at least 60% said they drank. Drinking among young adults had been trending downward, and Gallup notes that has only accelerated. Since 2023, the percentage of adults under 35 that reported drinking fell by nine percentage points, from 59% to 50%. Zoom in: The drop in women drinking from 2023 to 2025 has been more pronounced than it has among men, though both groups have seen a decline. Among partisans, there's a drinking divide: Among Republicans, the share who drink has dropped sharply in the last two years (19 percentage points), but there's only been a three-point slip for Democrats. State of play: Meanwhile, the majority of Americans — a first for Gallup's trend — say drinking in moderation (one or two drinks a day) is bad for one's health. That belief follows increases in 2023 and 2024, including a surge among young adults. Around 2001 to 2011, the share of U.S. adults who said moderate alcohol consumption was bad for one's health hovered around a quarter. Since 2023, a majority of 18- to 34-year-olds have viewed moderate drinking as bad for health. Follow the money: And as alcohol consumption has slipped, the nonalcoholic beverage sector has boomed. Bars and bottle shops in recent years have increasingly catered to the "sober-curious" as consumer behavior mirrors consumption trends. Zoom out: Research and health organization guidance on safe alcohol consumption has evolved in recent years. Notably, former U.S. surgeon general Vivek Murthy in January released an advisory detailing the link between alcohol consumption and several kinds of cancer and called on Congress to update warning labels on booze. The World Health Organization has emphasized that there is no safe amount of alcohol consumption that does not affect health, and the CDC warns that drinking in moderation may "increase your overall risks of death and chronic disease." The bottom line: Goodbye, "Dry January." Cheers to sober lifestyles. Methodology: Results are based on telephone interviews conducted by ReconMR July 7-21 2025, with a random sample of 1,002 adults. For results based on the total sample of national adults, the margin of sampling error is ±4 percentage points at the 95% confidence level.